This formulation aids in the prevention and treatment of vitamin B deficiencies, supports metabolic functions, and promotes general well-being in animals
Zimmermann, M., Kibe, T., Kabir, S
Rabow, S., Hjorth, U., Schnbeck, S
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
YJ: Resources, Writing original draft, Investigation, Methodology, Software
A: The IV drip Bangkok price varies based on the formula, number of sessions, and any package or promotion selected
